相关实验视频
Updated: Jul 8, 2026
08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
10.9K
自行驱动的受酶控制的红外半孔二氧化Janus纳米发动机用于智能交付
Beatriz Mayol1, Sandra Pradana-López1, Alba García2
1Nanosensors and Nanomachines Group, Department of Analytical Chemistry, Faculty of Chemistry, Complutense University of Madrid, 28040 Madrid, Spain.
Journal of colloid and interface science
|May 30, 2024
概括
研究人员开发了一种新的Janus纳米粒子,作为一种由酶驱动的纳米机器. 这种自行推进的纳米电机可以按需提供药物,提高癌细胞的释放效率.
科学领域:
- 纳米技术纳米技术
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
背景情况:
- 简斯纳米粒子为目标应用提供独特的特性.
- 酶驱动的纳米机器显示出对受控货物交付的承诺.
- 开发自动推进系统对于提高治疗疗效至关重要.
研究的目的:
- 创建一个新的Janus纳米粒子,具有自动推进能力,可在命令下进行药物输送.
- 设计一种由酶驱动的纳米机器,用于控制治疗剂的释放.
- 调查酶介导推进在增强货物释放方面的效率.
主要方法:
- 通过拓选择性修饰,制造具有明显的 (Ir) 和半孔面的Janus纳米粒子.
- 使用酸化学和葡萄糖氧化酶构建了pH敏感门和酶固定.
- 利用葡萄糖触发的酶反应 (H2O2和葡萄糖酸生产) 进行推进和货物释放.
主要成果:
- 成功准备了一台自动推进的Janus纳米粒子纳米机器.
- 通过添加葡萄糖引发的酶介导推进的演示,导致氧气的产生.
- 通过降低pH值诱导的门中断实现按需的货物释放.
- 验证了纳米电机在HeLa癌细胞中智能释放多克索鲁比辛的有效性.
结论:
- 以酶为媒介的自我推进显著提高了货物释放效率.
- 开发的纳米电机为命令式药物输送系统提供了一个平台.
- 这种方法具有针对性癌症治疗应用的潜力.
相关概念视频
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...